COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03380377
Brief Title: Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

First Submitted : August 3, 2017
First Submitted that Met QC Criteria : December 15, 2017
First Posted : December 21, 2017

Last Update Submitted that Met QC Criteria : March 19, 2020
Last Update Posted : March 20, 2020